---
title: Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies
  a high risk subgroup with inferior survival
date: '2024-04-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38648564/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240423181248&v=2.18.0.post9+e462414
source: Blood
description: A reciprocal t(3;8) BCL6::MYC fusion is common in large B cell lymphoma
  (LBCL) with MYC and BCL6 disruption. These pseudo-double hit cases are not adverse,
  whereas t(3;8) negative MYC/BCL6 lymphoma has an inferior prognosis relative to
  other MYC-rearranged ...
disable_comments: true
---
A reciprocal t(3;8) BCL6::MYC fusion is common in large B cell lymphoma (LBCL) with MYC and BCL6 disruption. These pseudo-double hit cases are not adverse, whereas t(3;8) negative MYC/BCL6 lymphoma has an inferior prognosis relative to other MYC-rearranged ...